Key facts, as of
As of November 6, 2026, Charles River Laboratories (CRL) trades at $337.52, up 97.5% over the past year. Its 52-week range runs from $146.20 to $379.63; the price is 11.1% below that high. It is 26.7% below its all-time high of $460.21, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +373.7%, against +316.3% for the S&P 500 (SPY). It sits 50.3% above its 200-day average of $224.56, and its 50-day average is above the 200-day too: an uptrend on both averages. Its 30-day volatility is 64.6% annualized, which we rate very high risk. It has a trailing P/E of 366.9.
Cite: Portfolio Terminal, "Charles River Laboratories (CRL) stock analysis", 2026-11-06. https://portfolio-terminal.com/analyse/crl
Where it trades today
trading 82% of the way up its 52-week range
How the price has moved
How far it is from its record
Charles River Laboratories (CRL) is 26.7% below its all-time high of $460.21, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +373.7%, against +316.3% for the S&P 500 (SPY).
The read, from its own figures
What its numbers say
- CRL closes above its 50-day average ($305.60), and the 50-day sits above the 200-day ($224.56): on both averages the chart reads as an uptrend.
- At $337.52, CRL is 11.1% below its 1-year high of $379.63, set on October 29, 2026, and 130.9% above its 1-year low of $146.20 (May 19, 2026).
- Over the past month CRL rose 13.3%, from $298.00 to $337.52.
- CRL trades at 366.9x its last twelve months of earnings and 26.3x the next twelve months' estimate, so analysts expect earnings 1295.3% higher.
- Its P/E is 901.2% above the 36.6x median of the 3 other diagnostics & research companies we track (TMO, DHR, A).
- CRL's 30-day volatility, 64.6% a year, works out to a typical daily move of about 4.1%.
- Yahoo Finance puts its beta at 1.34: over five years of monthly returns, CRL moved about 1.34% for each 1% move of the S&P 500.
What would change the read
- A close under the 50-day average, $305.60 (−9.5% from the last close), would turn the read to a pullback; under the 200-day, $224.56 (−33.5%), the longer rise is in question.
- A close above $379.63 (+12.5%) would be a new 1-year high; below $146.20 (−56.7%), a new 1-year low.
How it is computed
- Prices are Yahoo Finance's daily candles for CRL, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
- The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
- Peers are the other companies Yahoo Finance files under diagnostics & research among the assets we track, not a full industry screen; the median counts those with a positive P/E.
- Every sentence here is written by code from those figures, refreshed daily; nobody edits it for CRL by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.
Sources
- Yahoo Finance quote and daily historyopen →
The candles, the averages' inputs and the quote fields used for CRL. Last refresh: Nov 8, 2026, 10:53 PM UTC.
- How Portfolio Terminal computes its figuresopen →
The methodology page behind the analytics and their refresh cadence.
- Industry classification
Yahoo Finance's industry, as stored in our list of tracked assets: Diagnostics & Research.
What Charles River Laboratories does
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety…
What analysts expect
CRL carries a buy consensus from 15 analysts, with an average price target of $333.53 versus $337.52 today (-1.2%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
CRL generated $3.98B in trailing revenue (-2.2% year over year), with a 1.0% net margin, and $443.24M of free cash flow, against $2.65B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $4.02B | $1.32B | $401.14M | -$144.34M | -$2.91 | $518.49M |
| 2024 | $4.05B | $1.33B | $442.35M | $10.30M | $0.20 | $501.61M |
| 2023 | $4.13B | $1.50B | $617.26M | $474.62M | $9.27 | $365.37M |
| 2022 | $3.98B | $1.46B | $650.98M | $486.23M | $9.57 | $294.91M |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
CRL is in 11 of the 54 ETFs we track. It weighs most in XLV: 0.22% of the fund, holding #51 of 62.
How its figures compare with those peers
Companies in the same industry
CRL beside the other companies Yahoo Finance files under diagnostics & research among the assets we track (TMO, DHR, A, largest first).
CRLyou are here$337.52$16.17B
TMOThermo Fisher Scientific$694.76$257.42BDHDHRDanaher Corporation$230.25$161.99B
AAgilent Technologies$174.76$49.28BWhat the chart is saying
In an uptrend, above both moving averages.
uptrend- Price is 10.4% above its 50-day average and 50.3% above its 200-day.
- The 50-day crossed above the 200-day on 2026-07-06 (a “golden cross”).
- RSI at 54 is neither stretched nor washed out.
- Nothing above has stopped it this year; the nearest floor is $239.07 (-29.2%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
How is CRL valued right now?
Charles River Laboratories trades at 366.9 times its last twelve months of earnings and 26.3 times the next twelve months' estimate (Yahoo Finance, November 6, 2026). On the chart: in an uptrend, above both moving averages. Price is 10.4% above its 50-day average and 50.3% above its 200-day.
What is the risk level of CRL?
Based on 30-day volatility of 64.6%, CRL has VERY HIGH risk. Its beta of 1.34 means it has swung more than the S&P 500 over the last five years.
Does CRL pay dividends?
Yahoo Finance shows no dividend yield for Charles River Laboratories (November 6, 2026).
How far is CRL from its all-time high?
Charles River Laboratories is 26.7% below its all-time high of $460.21, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +373.7%, against +316.3% for the S&P 500 (SPY).
Which ETFs hold CRL?
11 of the 54 popular ETFs we track hold Charles River Laboratories. The largest weights: XLV (0.22%), RSP (0.22%), VB (0.18%), SPY (0.02%) and IVV (0.02%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.
How much of VOO is CRL?
0.02%, as of September 30, 2026: CRL is holding #430 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $0.21 in Charles River Laboratories.
What is the analyst price target for CRL?
The average analyst price target for Charles River Laboratories (CRL) is $333.53 based on 15 analyst estimates, about 1.2% below the current price of $337.52. The published range runs from $145.00 to $390.00.
How much revenue does CRL generate?
Charles River Laboratories reported $3.98B in trailing twelve-month revenue. Revenue growth is running at -2.2% year over year. Net margin sits at 1.0%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare CRL with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.